Some retrospective data shows patients on antidepressants lose slightly less weight overall on GLP-1 agonists, but this likely reflects the underlying depression rather than a pharmacological conflict
Studies have used MT-II alongside MC4R-selective agonists and MC4R knockout models to attribute the anorectic component of MT-IIs biology specifically to MC4R rather than MC3R activation
Activation of the glp-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell mass
Dose Increases and Medication Alternatives When Progress Stalls If you have maintained consistent healthy habits and a plateau persists beyond eight weeks, your prescriber may recommend a dose increase within the approved therapeutic range
If you want to know whether a B-vitamin injection is right for you, book a free consultation and we will base it on your actual levels
Your healthcare team should establish a monitoring schedule that includes assessment of both physical health markers (weight, blood glucose, blood pressure, lipid profile) and mental health indicators (mood stability, sleep quality, medication adherence)
